RA | Controls | P value | |
---|---|---|---|
M/F (n) | 4/9 | 5/6 | ns |
Age (years) | 52 (32–82) | 38 (26–73) | 0.05 |
Disease Duration (years) | 13 | - | - |
Rheumatoid-factor positive (%) | 11(85%) | - | - |
C-reactive protein (mg/L) | 14.5 (0.2–5.9) | 1 (0.4–2.9) | P<0.01 |
Disease activity score-28 (mean ± SD) | 4.5 ± 0.94 | — | — |
co-Morbidities: | |||
HTN | 0 | 1 | ns |
Hypothyroidism | 1 | 1 | ns |
SLE | 1 | 0 | ns |
Medications: | |||
Corticosteroids | 7 | 0 | 0.006 |
NSAIDS | 2 | 0 | ns |
β-Blockers | 2 | 0 | ns |
Calcium Channel Antagonists | 0 | 1 | ns |
DMARDs | 10 | 0 | 0.002 |
TNF receptor Blockers | 7 | 0 | 0.005 |